The reported 17.07% decrease in institutional ownership for Rani Therapeutics Holdings, Inc. (US:RANI) in the Most Recent Quarter (MRQ), including Orca Capital AG's substantial 56.55% reduction, is a significant data point for investors to consider.1 This collective divestment by institutional players often signals a shift in sentiment or a re-evaluation of the company's prospects, potentially leading to increased selling pressure on the stock.
Key observations from Fintel data include:
- Institutional Exodus: A reduction of 0.71 million shares by institutional investors, bringing the total institutional shares (long) to 3,443,979, reflects a notable decrease in conviction among some large holders.1 Orca Capital AG's decision to cut its stake by more than half, from 4,354,000 shares to 1,891,623, is particularly impactful given its prior ownership.1
- Bearish Market Sentiment: This institutional selling aligns with a strong bearish sentiment indicated by RANI's high short interest. The stock currently has 7,128,214 shares sold short, representing 23.87% of its float, with a Days to Cover ratio of 12.23 days.2 A high short interest suggests that a significant portion of the market expects the stock price to decline further.
- Divergent Analyst Views: Despite the institutional selling and high short interest, there appears to be a disconnect with analyst sentiment. Several firms, including HC Wainwright & Co., Canaccord Genuity, BTIG, and Oppenheimer, have maintained or initiated "Buy" or "Outperform" ratings on RANI, with an average one-year price target of $8.92.2 This target is substantially higher than the current share price of $0.54 as of August 6, 2025.2 This divergence warrants closer examination to understand the underlying rationale for both the institutional divestment and the optimistic analyst forecasts.
- Recent Performance: The stock has experienced a significant decline, with its share price decreasing by 78.28% over the past year.2
The combined effect of institutional selling and high short interest could create continued downward pressure on RANI's stock price. Investors should investigate the reasons behind this institutional shift and reconcile it with the more positive outlook from covering analysts.
